[Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].
D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D003556:Cystitis / Q000139:chemically induced / Q000517:prevention & control*; D006417:Hematuria / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects / Q000627:therapeutic use*; D008623:Mercaptoethanol / Q000031:analogs & derivatives*; D015080:Mesna / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy
D008623:Mercaptoethanol; D003520:Cyclophosphamide; D015080:Mesna; D007069:Ifosfamide
Kliniczna ocena preparatu mitexan w zapobieganiu powikłaniom ze strony dróg moczowych podczas leczenia holoxanem.